Targeting the sarcomere to correct muscle function
The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Abstract
Various human diseases can disrupt the balance between muscle contraction and relaxation. Sarcomeric modulators can be used to readjust this balance either indirectly by intervening in signalling pathways or directly through interaction with the muscle proteins that control contraction. Such agents represent a novel approach to treating any condition in which striated muscle function is compromised, including heart failure, cardiomyopathies, skeletal myopathies and a wide range of neuromuscular conditions. Here, we review agents that modulate the mechanical function of the sarcomere, focusing on emerging compounds that target myosin or the troponin complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the Z-disk is traditionally viewed as a structural component of the sarcomere, emerging evidence indicates Z-disks are epicenters for signaling in the sarcomere with a number of different kinases and phosphatases localized to the Z-disk (6, 50).”
From Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics (2020) · cites this paper as [6]
Citations
Cites
Items 201–207 of 207
Endoh, M. (2013) · Circulation Research · doi:10.1161/circresaha.113.301689 · Cited by 11
Bódi, A., Szilágyi, S., Edes, I. F., et al. (2003) · PubMed · Cited by 9
Bauer, T. A., Wolff, A. A., Hirsch, A. T., et al. (2014) · Vascular Medicine · doi:10.1177/1358863x14534516 · Cited by 9
On Mechanosensation, Acto/Myosin Interaction, and Hypertrophy
Knöll, R., & Marston, S. B. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.06.005 · Cited by 8
Investigation on SCH00013, a Novel Cardiotonic Agent with Ca++ Sensitizing Action
Hino, M., Sugawara, H., Yoshimura, A., et al. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300434 · Cited by 8
Investigation on SCH00013, a Novel Cardiotonic Agent with Ca++ Sensitizing Action
Sugawara, H., Hino, M., Yoshimura, A., et al. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300436 · Cited by 5
Rodrı́guez, H. M., Whitman-Cox, S., Kawas, R. F., et al. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2013.11.3123 · Cited by 4
Cited by
Tucholski, T., Cai, W., Gregorich, Z. R., Bayne, E. F., Mitchell, S. D., McIlwain, S. J., de Lange, W. J., Wrobbel, M., Karp, H., Hite, Z., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006764117 · Cited by 107
Deletion of Enigma Homologue from the Z-disc slows tension development kinetics in mouse myocardium
Gregorich, Z. R., Patel, J. R., Cai, W., Lin, Z., Heurer, R., Fitzsimons, D. P., Moss, R. L., & Ge, Y. (2019) · Journal of General Physiology · doi:10.1085/jgp.201812214 · Cited by 6
“In recent years, the importance of Z-discs, the protein-dense structures that anchor the antiparallel actin filaments from adjoining sarcomeres, in muscle has been underscored by the identification of a growing list of mutations in Z-disc proteins in patients with cardiac and skeletal muscle myopathies (Knöll et al.,…”
Background
Metadata
- Authors
- Hwang, P. M., & Sykes, B. D.
- Affiliations
- University of Alberta (CA)
- Corresponding author
- Sykes, Brian D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-04-17
- Volume
- 14
- Issue
- 5
- Pages
- 313-328
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2040264002
- Cited by
- 114
- References
- 207
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 8 · 2020: 13 · 2019: 9 · 2018: 21 · 2017: 11 · 2016: 18 · 2015: 3
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Canadian Institutes of Health Research (37769)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- sarcomere, myosin, troponin complex, muscle contraction and relaxation, heart failure, cardiomyopathy, skeletal myopathy, neuromuscular disorders
- MeSH terms
- Animals, Heart Failure, Humans, Muscle Contraction, Muscle Proteins, Muscular Diseases, Cardiomyopathies, Neuromuscular Diseases, Sarcomeres, Signal Transduction, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.